ProCE Banner Activity

ExpressPoints: Applying Current Evidence to Improve Outcomes for Patients With Myeloproliferative Neoplasms

Slideset Download
Download this short summary slideset of key takeaway points on how experts approach the management of patients with myelofibrosis, polycythemia vera, and essential thrombocythemia.

Released: March 02, 2022

Expiration: March 01, 2023

No longer available for credit.

Share

Faculty

Prithviraj Bose

Prithviraj Bose, MD

Professor
Department of Leukemia
UT MD Anderson Cancer Center
Houston, Texas

Stephen Oh

Stephen Oh, MD, PhD

Associate Professor of Medicine
Co-Chief, Division of Hematology
Washington University School of Medicine
St Louis, Missouri

Brady L. Stein

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Geron

Incyte Corporation

Sumitomo Dainippon Pharma ONC

Faculty Disclosure

Primary Author

Prithviraj Bose, MD

Professor
Department of Leukemia
UT MD Anderson Cancer Center
Houston, Texas

Prithviraj Bose, MD, has disclosed that he has received funds for research support from Astellas, Blueprint, Bristol-Myers Squibb, Cogent, Constellation, CTI BioPharma, Incyte, Ionis, Kartos, NS Pharma, Pfizer, and Promedior and consulting fees from AbbVie, Blueprint, Bristol-Myers Squibb, CTI BioPharma, Incyte, Karyopharm, Novartis, Pharma Essentia, and Sierra Oncology.

Stephen Oh, MD, PhD

Associate Professor of Medicine
Co-Chief, Division of Hematology
Washington University School of Medicine
St Louis, Missouri

Stephen Oh, MD, PhD, has disclosed that he has received consulting fees from AbbVie, Blueprint, Bristol-Myers Squibb, Constellation, CTI Biopharma, Disc Medicine, Geron, Incyte, Pharmaessentia, and Sierra Oncology.

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Brady L. Stein, MD, MHS, has disclosed that he has received consulting fees from Apexx Oncology and Celgene.